Galen (Galen MRI Systems Limited) specializes in developing new-generation MRI systems that aim to better facilitate medical professional on diagnosis through MRI imaging platform advancement. Currently, Galen is working with Dr. Christopher Comstock, radiologist at Memorial Sloan Kettering Cancer Center (MSKCC) in New York on the world’s innovative breast MRI device. Driven by a team comprised of engineers, healthcare executives and business leaders in finance, public policy and solutions marketing. With published papers and global patents, the group owns a strong intellectual property portfolio including the IP transferred from Columbia University and The University of Hong Kong. The R&D team, originated from Columbia University and Harvard Medical School, designs, develops and manufactures good value, high performance and high technology MRI systems. Galen based in Hong Kong Science and Technology Parks (HKSTP), a place where opportunity, innovation, creativity and entrepreneurship converge. It is a dynamic physical and cultural hub with world-class infrastructure, Asia's most strategic location, and a global network of people with an impressive record of success that can support achievement in scientific, technological and clinical excellence. Hong Kong, a vibrant city as well as home to one of the oldest medical school in Far East, here our motivated team are dedicated in developing solutions to pursuit different clinical needs.